Olmesartan E Idroclorotiazide Sandoz (Olmesartan Medoxomil, Hydrochlorothiazide)

Olmesartan medoxil, the active ingredient in Olmesartan E Idroclorotiazide Sandoz, is an angiotensin II receptor blocker presented as a tablet for oral use. It treats hypertension, often in combination with a diuretic, and is suitable for adult patients. GNH USA supplies Olmesartan E Idroclorotiazide Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olmesartan E Idroclorotiazide Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Olmesartan medoxil combined with hydrochlorothiazide is used to manage blood pressure through the renin‑angiotensin system and diuretic pathways.

- Hypertension: lowers systolic and diastolic blood pressure in patients with primary hypertension. - Hypertension with fluid retention: improves blood pressure control when excess fluid contributes to elevated readings. - High‑risk cardiovascular patients: contributes to risk reduction in patients with hypertension and additional cardiovascular risk factors. - Chronic kidney disease related hypertension: assists in managing blood pressure where kidney function is impaired. - Post‑stroke rehabil rehabilitation by    -  

The     … …  … ...  …  … ...

****  

****